Pathological omics prediction of early and advanced colon cancer based on artificial intelligence model.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-03119-5
- By:
- Publication type:
- Article
Works matching AU Wang, Kuanyu
Results: 35
1
2
HDAC4, a prognostic and chromosomal instability marker, refines the predictive value of MGMT promoter methylation.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 122, n. 2, p. 303, doi. 10.1007/s11060-014-1709-6
- By:
- Publication type:
- Article
3
Exosomal miRNAs in pancreatitis: Mechanisms and potential applications (Review).
- Published in:
- Molecular Medicine Reports, 2025, v. 32, n. 2, p. N.PAG, doi. 10.3892/mmr.2025.13575
- By:
- Publication type:
- Article
4
miR-205 suppresses cell migration, invasion and EMT of colon cancer by targeting mouse double minute 4.
- Published in:
- Molecular Medicine Reports, 2020, v. 22, n. 2, p. 633, doi. 10.3892/mmr.2020.11150
- By:
- Publication type:
- Article
5
Identification of an ATP metabolism‐related signature associated with prognosis and immune microenvironment in gliomas.
- Published in:
- Cancer Science, 2020, v. 111, n. 7, p. 2325, doi. 10.1111/cas.14484
- By:
- Publication type:
- Article
6
A comprehensive review of available omics data resources and molecular profiling for precision glioma studies.
- Published in:
- Biomedical Reports, 2019, v. 10, n. 1, p. 3
- By:
- Publication type:
- Article
7
Factors Affecting Volume Reduction Velocity for Arteriovenous Malformations After Treatment With Dose-Stage Stereotactic Radiosurgery.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.769533
- By:
- Publication type:
- Article
8
Primary Central Nervous System Lymphoma (PCNSL) Following Thyroid Cancer Surgery: A Case Report of Misdiagnosed Brain Metastasis and Literature Review.
- Published in:
- Current Oncology, 2024, v. 31, n. 12, p. 7555, doi. 10.3390/curroncol31120556
- By:
- Publication type:
- Article
9
Comprehensive analysis of the clinical and biological significances of cholesterol metabolism in lower-grade gliomas.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10897-0
- By:
- Publication type:
- Article
10
Molecular and clinical characterization of PTRF in glioma via 1,022 samples.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11001-2
- By:
- Publication type:
- Article
11
Expression profile analysis of antisense long non-coding RNA identifies WDFY3-AS2 as a prognostic biomarker in diffuse glioma.
- Published in:
- Cancer Cell International, 2018, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12935-018-0603-2
- By:
- Publication type:
- Article
12
A novel DNA damage response signature of IDH-mutant grade II and grade III astrocytoma at transcriptional level.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 3, p. 579, doi. 10.1007/s00432-020-03132-x
- By:
- Publication type:
- Article
13
A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 3, p. 439, doi. 10.1007/s00432-017-2572-6
- By:
- Publication type:
- Article
14
Exploring the Role of Ccn3 in Type III Cell of Mice Taste Buds.
- Published in:
- Journal of Neurochemistry, 2025, v. 169, n. 1, p. 1, doi. 10.1111/jnc.16291
- By:
- Publication type:
- Article
15
Novel roles of VAT1 expression in the immunosuppressive action of diffuse gliomas.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 9, p. 2589, doi. 10.1007/s00262-021-02865-z
- By:
- Publication type:
- Article
16
Impacts of Fuzhengxiaoyan decoction on immune functions in nude mice bearing EMT-6 breast cancer.
- Published in:
- European Journal of Gynaecological Oncology, 2018, v. 39, n. 1, p. 133, doi. 10.12892/ejgo3927.2018
- By:
- Publication type:
- Article
17
Surveying brain tumor heterogeneity by single-cell RNA-sequencing of multi-sector biopsies.
- Published in:
- National Science Review, 2020, v. 7, n. 8, p. 1306, doi. 10.1093/nsr/nwaa099
- By:
- Publication type:
- Article
18
Receptor tyrosine kinase expression in high-grade gliomas before and after chemoradiotherapy.
- Published in:
- Oncology Letters, 2019, v. 18, n. 6, p. 6509, doi. 10.3892/ol.2019.11017
- By:
- Publication type:
- Article
19
RELB: A novel prognostic marker for glioblastoma as identified by population-based analysis.
- Published in:
- Oncology Letters, 2019, v. 18, n. 1, p. 386, doi. 10.3892/ol.2019.10296
- By:
- Publication type:
- Article
20
Survivin is a prognostic indicator in glioblastoma and may be a target of microRNA-218.
- Published in:
- Oncology Letters, 2019, v. 18, n. 1, p. 359, doi. 10.3892/ol.2019.10335
- By:
- Publication type:
- Article
21
Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma.
- Published in:
- Journal of Neurosurgery, 2017, v. 126, n. 1, p. 249, doi. 10.3171/2015.11.JNS15432
- By:
- Publication type:
- Article
22
Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma.
- Published in:
- Journal of Neurosurgery, 2016, v. 125, n. 1, p. 7, doi. 10.3171/2015.5.JNS142437
- By:
- Publication type:
- Article
23
Comprehensive profiling identifies a novel signature with robust predictive value and reveals the potential drug resistance mechanism in glioma.
- Published in:
- Cell Communication & Signaling, 2020, v. 18, n. 1, p. 1, doi. 10.1186/s12964-019-0492-6
- By:
- Publication type:
- Article
24
Role of flavonoids in inhibiting triple-negative breast cancer.
- Published in:
- Frontiers in Pharmacology, 2024, p. 01, doi. 10.3389/fphar.2024.1411059
- By:
- Publication type:
- Article
25
High expression of VAT1 is a prognostic biomarker and predicts malignancy in glioblastoma.
- Published in:
- Oncology Reports, 2019, v. 42, n. 4, p. 1422, doi. 10.3892/or.2019.7276
- By:
- Publication type:
- Article
26
CKAP2 expression is associated with glioma tumor growth and acts as a prognostic factor in high-grade glioma.
- Published in:
- Oncology Reports, 2018, v. 40, n. 4, p. 2036, doi. 10.3892/or.2018.6611
- By:
- Publication type:
- Article
27
PATH-60. BIOINFORMATIC PROFILING IDENTIFIES THE SECRETED GLYCOPROTEIN ADAMTSL4 TO BE A POTENTIAL NOVEL IMMUNE-RELATED BIOMARKER FOR PRIMARY GLIOBLASTOMA.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi171, doi. 10.1093/neuonc/noy148.714
- By:
- Publication type:
- Article
28
ADAR3 expression is an independent prognostic factor in lower-grade diffuse gliomas and positively correlated with the editing level of GRIA2<sup>Q607R</sup>.
- Published in:
- Cancer Cell International, 2018, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12935-018-0695-8
- By:
- Publication type:
- Article
29
A reactive oxygen species-related signature predicts the prognosis and immunosuppressive microenvironment in gliomas.
- Published in:
- Redox Report, 2024, v. 29, n. 1, p. 1, doi. 10.1080/13510002.2024.2433396
- By:
- Publication type:
- Article
30
A Novel TNFSF-Based Signature Predicts the Prognosis and Immunosuppressive Status of Lower-Grade Glioma.
- Published in:
- BioMed Research International, 2022, p. 1, doi. 10.1155/2022/3194996
- By:
- Publication type:
- Article
31
Molecular Characterization of AEBP1 at Transcriptional Level in Glioma.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/5579359
- By:
- Publication type:
- Article
32
circRNA disease: a manually curated database of experimentally supported circRNA-disease associations.
- Published in:
- Cell Death & Disease, 2018, v. 9, n. 5, p. 1, doi. 10.1038/s41419-018-0503-3
- By:
- Publication type:
- Article
33
High‐sensitive clinical diagnostic method for PTPRZ1‐MET and the characteristic protein structure contributing to ligand‐independent MET activation.
- Published in:
- CNS Neuroscience & Therapeutics, 2021, v. 27, n. 5, p. 617, doi. 10.1111/cns.13627
- By:
- Publication type:
- Article
34
RGS16 promotes glioma progression and serves as a prognostic factor.
- Published in:
- CNS Neuroscience & Therapeutics, 2020, v. 26, n. 8, p. 791, doi. 10.1111/cns.13382
- By:
- Publication type:
- Article
35
Pathway‐based stratification of gliomas uncovers four subtypes with different TME characteristics and prognosis.
- Published in:
- Journal of Cellular & Molecular Medicine, 2024, v. 28, n. 8, p. 1, doi. 10.1111/jcmm.18208
- By:
- Publication type:
- Article